Search Results - "Barthel, Henryk"

Proven validity and management impact of amyloid imaging in Alzheimer's disease—repetita juvant.

Authors: Barthel, Henryk Arbizu, Javier Drzezga, Alexander et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2020, Vol. 47 Issue 8, p1787-1790. 4p.

PET imaging utilization and trends in Germany: a comprehensive survey.

Authors: Holzgreve, Adrien Hellwig, Dirk Barthel, Henryk et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2025, Vol. 52 Issue 12, p4390-4398. 9p.

Biologic Definition of Parkinson Disease: A Pivotal Role for Molecular Imaging.

Authors: Brendel, Matthias Barthel, Henryk Höglinger, Günter U.

Source: Journal of Nuclear Medicine. Jun2026, Vol. 67 Issue 6, p833-840. 8p.

Author Index.

Source: Journal of Labelled Compounds & Radiopharmaceuticals. May2019 Supplement S1, Vol. 62, pS589-S603. 15p.

Connectivity as a universal predictor of tau progression in atypical Alzheimer's disease.

Authors: Bruin, Hannah de Groot, Colin Barthel, Henryk et al.

Source: Brain: A Journal of Neurology; Nov2025, Vol. 148 Issue 11, p3893-3912, 20p

Neuroimaging biomarkers in the biological definition of Parkinson's disease and dementia with Lewy bodies – EANM position on current state, unmet needs and future perspectives.

Authors: Brendel, Matthias Guedj, Eric Yakushev, Igor et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2024, Vol. 51 Issue 12, p3496-3500. 5p.

2-[¹⁸F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee.

Authors: Verger, Antoine Barthel, Henryk Tolboom, Nelleke et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Sep2022, Vol. 49 Issue 11, p3599-3606. 8p. 2 Color Photographs.

Additive value of [¹⁸F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome.

Authors: Katzdobler, Sabrina Nitschmann, Alexander Barthel, Henryk et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jan2023, Vol. 50 Issue 2, p423-434. 12p. 1 Color Photograph, 2 Charts, 3 Graphs.

Imaging and Fluid Biomarkers of Alzheimer Disease: Complementation Rather Than Competition.

Authors: Drzezga, Alexander Barthel, Henryk

Source: Journal of Nuclear Medicine. 2025 Supplement 2, Vol. 66 Issue 6, pS32-S44. 13p.

Exploring the origins of frequent tau-PET signal in vermal and adjacent regions.

Authors: Kling, Agnes Kusche-Palenga, Julia Palleis, Carla et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Aug2025, Vol. 52 Issue 10, p3519-3533. 15p.

Funding Reductions Threaten the Future of Medical Innovation.

Authors: Czernin, Johannes Anderson, Carolyn J. Badawi, Ramsey Derek et al.

Source: Journal of Nuclear Medicine. Jun2025, Vol. 66 Issue 6, p829-829. 1p.

EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours.

Authors: Van Weehaeghe, Donatienne Lapauw, Bruno Fraioli, Francesco et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2024, Vol. 51 Issue 8, p2367-2370. 4p.

Multi-parametric [¹⁸F]PI-2620 tau PET/MRI for the phenotyping of different Alzheimer's disease variants.

Authors: Rullmann, Michael Henssen, Dylan Melasch, Juliana T. et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jun2025, Vol. 52 Issue 7, p2279-2289. 11p.

Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease.

Authors: Barba, Lorenzo Abu-Rumeileh, Samir Barthel, Henryk et al.

Source: Brain: A Journal of Neurology; Oct2024, Vol. 147 Issue 10, p3325-3343, 19p

Feasibility of short imaging protocols for [¹⁸F]PI-2620 tau-PET in progressive supranuclear palsy.

Authors: Song, Mengmeng Scheifele, Maximilian Barthel, Henryk et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Nov2021, Vol. 48 Issue 12, p3872-3885. 14p. 1 Color Photograph, 1 Black and White Photograph, 5 Charts, 3 Graphs.

EANM position paper: theranostics in brain tumours—the present and the future.

Authors: Tolboom, Nelleke Verger, Antoine Albert, Nathalie L. et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Dec2023, Vol. 51 Issue 1, p202-205. 4p.

Correction to: EANM procedure guidelines for brain PET imaging using [¹⁸F]FDG, version 3.

Authors: Guedj, Eric Varrone, Andrea Boellaard, Ronald et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. May2022, Vol. 49 Issue 6, p2100-2101. 2p.

EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy.

Authors: Traub-Weidinger, Tatjana Arbizu, Javier Barthel, Henryk et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jun2024, Vol. 51 Issue 7, p1891-1908. 18p.

Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies.

Authors: Ferschmann, Christian Messerschmidt, Konstantin Gnörich, Johannes et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Jun2024, Vol. 51 Issue 7, p1909-1922. 14p.

COVID-19 and the brain: impact on nuclear medicine in neurology.

Authors: Morbelli, Silvia Ekmekcioglu, Ozgul Barthel, Henryk et al.

Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2020, Vol. 47 Issue 11, p2487-2492. 6p.